GE Healthcare Technologies, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US36266G1076
USD
82.52
2.3 (2.87%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
5,007.00
4,777.00
5,319.00
4,863.00
4,839.00
4,650.00
5,206.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,007.00
4,777.00
5,319.00
4,863.00
4,839.00
4,650.00
5,206.00
Raw Material Cost
3,075.00
2,781.00
3,065.00
2,877.00
2,844.00
2,733.00
3,004.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
120.00
117.00
126.00
134.00
135.00
122.00
167.00
Selling and Distribution Expenses
1,003.00
983.00
1,006.00
962.00
1,004.00
983.00
1,022.00
Other Expenses
18.20
22.70
21.80
18.20
19.20
20.20
14.80
Total Expenditure (Excl Depreciation)
4,380.00
4,108.00
4,415.00
4,155.00
4,175.00
4,040.00
4,341.00
Operating Profit (PBDIT) excl Other Income
627
669
904
708
664
610
865
Other Income
77.00
99.00
151.00
115.00
107.00
82.00
53.00
Operating Profit (PBDIT)
851.00
904.00
1,195.00
966.00
921.00
840.00
1,062.00
Interest
120.00
117.00
126.00
134.00
135.00
122.00
167.00
Exceptional Items
28.00
40.00
-95.00
-33.00
-58.00
-59.00
-142.00
Gross Profit (PBDT)
1,932.00
1,996.00
2,254.00
1,986.00
1,995.00
1,917.00
2,202.00
Depreciation
147.00
136.00
140.00
143.00
150.00
148.00
144.00
Profit Before Tax
613.00
692.00
834.00
658.00
578.00
512.00
609.00
Tax
113.00
104.00
96.00
168.00
143.00
124.00
193.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
486.00
564.00
721.00
471.00
428.00
374.00
403.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
486.00
564.00
721.00
471.00
428.00
374.00
403.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
14.00
24.00
17.00
19.00
7.00
14.00
13.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
500.00
588.00
738.00
490.00
435.00
388.00
416.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
9,713.00
9,188.00
8,447.00
8,317.00
7,801.00
7,408.00
7,133.00
Earnings per share (EPS)
1.06
1.23
1.57
1.02
0.93
0.81
0.88
Diluted Earnings per share
1.06
1.23
1.57
1.02
0.93
0.81
0.88
Operating Profit Margin (Excl OI)
12.52%
14.0%
17.0%
14.56%
13.72%
13.12%
16.62%
Gross Profit Margin
15.18%
17.33%
18.31%
16.47%
15.04%
14.19%
14.46%
PAT Margin
9.71%
11.81%
13.56%
9.69%
8.84%
8.04%
7.74%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 3.47% vs 0.46% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 14.94% vs 0.46% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is -4.91% vs 11.66% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is -11.11% vs -1.46% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024

Compare Quarterly Results Of GE Healthcare Technologies, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
5,007.00
1,738.00
3,269.00
188.09%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,007.00
1,738.00
3,269.00
188.09%
Raw Material Cost
3,075.00
838.00
2,237.00
266.95%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
120.00
28.00
92.00
328.57%
Selling and Distribution Expenses
1,003.00
404.00
599.00
148.27%
Other Expenses
18.20
8.30
9.90
119.28%
Total Expenditure (Excl Depreciation)
4,380.00
1,353.00
3,027.00
223.73%
Operating Profit (PBDIT) excl Other Income
627.00
385.00
242.00
62.86%
Other Income
77.00
28.00
49.00
175.00%
Operating Profit (PBDIT)
851.00
485.00
366.00
75.46%
Interest
120.00
28.00
92.00
328.57%
Exceptional Items
28.00
-19.00
47.00
247.37%
Gross Profit (PBDT)
1,932.00
900.00
1,032.00
114.67%
Depreciation
147.00
72.00
75.00
104.17%
Profit Before Tax
613.00
366.00
247.00
67.49%
Tax
113.00
30.00
83.00
276.67%
Provisions and contingencies
0
0
0.00
Profit After Tax
486.00
336.00
150.00
44.64%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
486.00
336.00
150.00
44.64%
Share in Profit of Associates
0
0
0.00
Minority Interest
14.00
0.00
14.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
500.00
336.00
164.00
48.81%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
9,713.00
6,370.00
3,343.00
52.48%
Earnings per share (EPS)
1.06
1.18
-0.12
-10.17%
Diluted Earnings per share
1.06
1.18
-0.12
-10.17%
Operating Profit Margin (Excl OI)
12.52%
22.15%
0.00
-9.63%
Gross Profit Margin
15.18%
25.20%
0.00
-10.02%
PAT Margin
9.71%
19.33%
0.00
-9.62%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 500.70 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 4.81% vs -10.19% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 3.47% vs 0.46% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 50.00 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -14.97% vs -20.33% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 14.94% vs 0.46% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 77.40 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -3.85% vs -22.89% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -4.91% vs 11.66% in Jun 2024

Quarterly - Interest
Interest 12.00 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 2.56% vs -7.14% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -11.11% vs -1.46% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.52%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024